Table 1.
Baseline characteristics of patients (n = 85)
| Variable | Value |
|---|---|
| Demographic and clinical parameters | |
| Age, years (median, IQR) | 65 (53–74) |
| Women, n (%) | 12 (14.1) |
| Smokers, n (%) | |
| Current | 26 (30.6) |
| Former | 7 (8.2) |
| BMI, kg/m2 (mean, SD) | 27.7 (4.6) |
| RR syst., mmHg (mean, SD) | 145.6 (27.7) |
| Lipid-lowering therapy at baseline, n (%) | |
| High-intensity statin | 3 (3.5) |
| Moderate-intensity statin | 7 (8.2) |
| Low-intensity statin | 2 (2.4) |
| High-intensity statin + ezetimibe | 1 (1.2) |
| High-intensity statin + ezetimibe + PCSK9mab | 1 (1.2) |
| Laboratory values | |
| Total cholesterol, mmol/L (mean, SD) | 4.6 (1.2) |
| LDL-C, mmol/L (mean, SD) | 3.2 (1.2) |
| HDL-C, mmol/L (mean, SD) | 1.2 (0.3) |
| TG, mmol/L (mean, SD) | 1.3 (1.3) |
| Lipoprotein (a), nmol/L (median, IQR) | 21.0 (20.0–67.5) |
| Troponin, pg/ml (median, IQR) | 3234.0 (1013.0–6830.2) |
| HbA1C, % (mean, SD) | 5.9 (0.8) |
| eGFR, ml/Min (median, IQR) | 80.8 (68.0–91.3) |
| Comorbidities, n (%) | |
| Diabetes | 13 (15.3) |
| Hypertension | 54 (63.5) |
Continuous variables are shown as median (IQR) or mean (SD), categorical variables are n (%). For lipids: multiply by 38.66976 to convert mmol/L to mg/dL